Biotech Growth (Ordinary Share) BIOG

Objective:

Management Contract & Fees:

Under a new management, administration and company secretarial agreement with Frostrow Capital LLP, Frostrow will receive a periodic fee equal to 0.30% per annum of the Companys market capitalisation plus a fixed amount equal to GBP 50,000 per annum. Fees payable under the new agreement will apply from 1 July 2007. A performance fee is calculated quarterly by comparing the cumulative performance of the Companys investment portfolio with the cumulative performance of the benchmark index since 30-Jun-05. The performance fee amounts to 16.5% of any out-performance of the NAV over the benchmark index. At each quarterly calculation date any performance fee payable is based on the lower of: (i)the cumulative out-performance of the investment portfolio over the benchmark index as at the quarter end date; and (ii) the cumulative out-performance of the investment portfolio over the benchmark as at the corresponding quarter end date in the previous year.